000 | 01993 a2200565 4500 | ||
---|---|---|---|
005 | 20250517114951.0 | ||
264 | 0 | _c20170621 | |
008 | 201706s 0 0 eng d | ||
022 | _a1096-8652 | ||
024 | 7 |
_a10.1002/ajh.24559 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBenhamou, Ygal | |
245 | 0 | 0 |
_aEfficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study. _h[electronic resource] |
260 |
_bAmerican journal of hematology _c12 2016 |
||
300 |
_a1246-1251 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aADAMTS13 Protein _xblood |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHistorically Controlled Study |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLymphocyte Depletion |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPlasma Exchange |
650 | 0 | 4 | _aPlatelet Count |
650 | 0 | 4 |
_aPurpura, Thrombotic Thrombocytopenic _xdrug therapy |
650 | 0 | 4 |
_aRituximab _xadministration & dosage |
700 | 1 | _aPaintaud, Gilles | |
700 | 1 | _aAzoulay, Elie | |
700 | 1 | _aPoullin, Pascale | |
700 | 1 | _aGalicier, Lionel | |
700 | 1 | _aDesvignes, Céline | |
700 | 1 | _aBaudel, Jean-Luc | |
700 | 1 | _aPeltier, Julie | |
700 | 1 | _aMira, Jean-Paul | |
700 | 1 | _aPène, Frédéric | |
700 | 1 | _aPresne, Claire | |
700 | 1 | _aSaheb, Samir | |
700 | 1 | _aDeligny, Christophe | |
700 | 1 | _aRousseau, Alexandra | |
700 | 1 | _aFéger, Frédéric | |
700 | 1 | _aVeyradier, Agnès | |
700 | 1 | _aCoppo, Paul | |
773 | 0 |
_tAmerican journal of hematology _gvol. 91 _gno. 12 _gp. 1246-1251 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.24559 _zAvailable from publisher's website |
999 |
_c26431308 _d26431308 |